規制医薬品への子どものアクセス:政策の教訓,介入の優先順位,行動の枠組み
Maria-Belen Tarrafeta-Sayas1, Brandon Maser2, Ximena García-Quintero3
1Department of Public Health, Institute of Tropical Medicine, Antwerp, Antwerp Province, Belgium.
The Lancet. Child & adolescent health
|February 21, 2026
まとめ
低所得国の子どもたちは,必要不可欠な規制医薬品へのアクセスに重大な障壁に直面しています. この研究は,小児の集団にとってこれらの重要な医薬品への公平なアクセスを改善するための政策ソリューションと枠組みを提供します.
科学分野:
- 健康政策 保健政策 保健政策
- グローバル・ヘルス グローバル・ヘルス
- 医薬品へのアクセス
背景:
- 低・中所得国 (LMICs) の子どもたちは,規制医薬品へのアクセスに重大な課題に直面しています.
- 小児のコントロールされた医薬品へのアクセスの既存の障壁は,包括的な,政策主導の,システムレベルの介入を必要とします.
- この世界的な不平等に対処するための効果的な政策戦略に関する研究が不可欠です.
研究 の 目的:
- 子どものための規制医薬品へのアクセスを改善するための政策ガイドラインとリソースをレビューする.
- LMIC (ウガンダ,インド,コスタリカ) から引き継がれる政策の教訓を強調する.
- 研究と介入の優先順位と,実行可能なレバーの枠組みを提案する.
主な方法:
- 関連する政策指針とリソースの有意義なレビュー.
- 3つの低・中所得国からの政策教訓の分析.
- 文献の統合と多学科の専門家の投入.
主要な成果:
- アクセスを改善するための主要な政策の教訓と実行可能なレバーを特定しました.
- 小児のコントロールされた医薬品へのアクセスを強化するための戦略を概説する機能的枠組みを開発しました.
- 状況特有のシステムレベルの政策介入の重要性を強調した.
結論:
- 小児の制御医療へのアクセスにおける世界的な不平等に対処するには,ターゲットを絞った政策とシステムレベルのアプローチが必要です.
- 移行可能な政策の教訓と専門家の指導は,効果的な介入の開発に不可欠です.
- 提案されたフレームワークは,子供向けの規制医薬品への適切なアクセスを改善するための実行可能なステップを提供します.
関連する概念動画
01:03Drug Control Governance: Regulatory Bodies and Their Impact
612
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
612
01:26Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
356
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
01:02Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
276
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
302
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302